Epilepsy is a neurological disorder that affects millions of people worldwide. Over the years, significant advancements have been made in its management, providing new hope for patients and healthcare professionals alike.
Technological advancements have led to the development of more precise diagnostic tools. High-density EEGs and 3D-MRI imaging now allow for a more accurate localization of seizure foci. These tools have not only improved the diagnostic accuracy but also made it possible to identify surgical candidates earlier.
Newer antiepileptic drugs (AEDs) have been developed with better efficacy and fewer side effects. Drugs such as Brivaracetam and Perampanel have shown promising results in controlling seizures. Additionally, the use of CBD-based Epidiolex has been approved for certain types of epilepsy, expanding the therapeutic options.
Surgical management of epilepsy has also evolved, with minimally invasive techniques such as Laser Interstitial Thermal Therapy (LITT) and Responsive Neurostimulation (RNS) gaining popularity. These techniques have less postoperative morbidity and can be an option for patients who are not candidates for traditional resective surgery.
Neuromodulation therapies such as Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), and Transcranial Magnetic Stimulation (TMS) have emerged as effective adjunctive treatments. These therapies offer an alternative for patients who do not respond to pharmacological treatments or are not suitable for surgery.
The advancements in epilepsy management have significantly improved the quality of life for many patients. As healthcare professionals, it is imperative to stay updated with these advancements to provide the best care possible. These innovations, coupled with a personalized approach to treatment, will continue to improve the prognosis and quality of life for individuals living with epilepsy.
1.
Advancing Health in Africa
2.
Financial hardship common in patients with cancer
3.
Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.
4.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
5.
New study links air pollution with higher rates of head and neck cancer
1.
Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches
2.
Care Planning for Chronic Blood Disorders
3.
Circulating Tumor DNA in Early Cancer Detection
4.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
5.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Understanding the Role of Screening in Cancer Prevention
3.
Innovations in Hematology
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Understanding the Importance of Follow-Up After Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation